Cancer Family
Glandular Cell Neoplasm
CI-CAN-00000188Explore in graph →
Non-malignant2,825 active trials43 approved drugs426 evidence items
- NCIt
- C7132
Loading cancer entity…
Cancer Family
CI-CAN-00000188Explore in graph →
Clinical trials
10,213 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03676075 | A Multi-center Trial to Establish a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA | unknown | — | 1,500 | Fudan UniversityOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT01037049 | Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks | unknown | Phase 2 | 237 | Royal Marsden NHS Foundation TrustOTHER | 4 | Sep 17, 2018 |
| NCT01995942 | Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial(MARVEL) | unknown | — | 246 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 14, 2018 | clinicaltrials |
| NCT03005756 | Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma Patients(NGR) | unknown | N/A | 20 | Asan Medical CenterOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT03661671 | Application of Linked Color Imaging(LCI) in Diagnosis of Early Gastric Cancer(EGC) | unknown | N/A | 2,400 | Changhai HospitalOTHER | 1 | Sep 7, 2018 | clinicaltrials |
| NCT03050047 | A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 15 | BiocadINDUSTRY | 1 | Aug 31, 2018 | clinicaltrials |
| NCT03652896 | Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma | unknown | N/A | 60 | Huazhong University of Science and TechnologyOTHER | 1 | Aug 29, 2018 | clinicaltrials |
| NCT03228095 | Volatiles in Breath and Headspace Analysis - Diagnostic Markers(Volatolome) | unknown | — | 3,000 | University of LatviaOTHER | 1 | Aug 21, 2018 | clinicaltrials |
| NCT03639662 | Psychological Impact of a Sophrological Accompaniment During the Announcement of Thyroid Cancer | unknown | N/A | 232 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 21, 2018 | clinicaltrials |
| NCT02293850 | Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma | unknown | Phase 1 | 18 | Oncolys BioPharma IncINDUSTRY | 2 | Aug 20, 2018 | clinicaltrials |
| NCT03636685 | Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC | unknown | Phase 1 / Phase 2 | 60 | Chinese Academy of Medical SciencesOTHER | 0 | Aug 17, 2018 | clinicaltrials |
| NCT03632746 | Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients | unknown | — | 80 | Zhaode Bu, MDOTHER | 1 | Aug 15, 2018 | clinicaltrials |
| NCT02919878 | Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer | unknown | Phase 2 | 25 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT02919371 | Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA) | unknown | Phase 1 / Phase 2 | 77 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT02525068 | A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC(RE-AKT) | unknown | Phase 2 | 136 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT02138981 | Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | unknown | Phase 4 | 436 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03469479 | Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | unknown | Phase 3 | 252 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03612674 | Adenoma Detection Rate With Endocuff-Assisted Colonoscopy - an Italian Trial(ITAvision) | unknown | N/A | 2,100 | Cancer Prevention and Research Institute, ItalyOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03609151 | Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma | unknown | N/A | 110 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT03609268 | Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma | unknown | N/A | 110 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT03591315 | Clinical Study of Structural and Functional Evaluation of the Visual Pathway | unknown | — | 60 | Xiangya Hospital of Central South UniversityOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT03594929 | Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery | unknown | N/A | 50 | Singapore General HospitalOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT03591666 | A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas | unknown | Phase 2 | 51 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Jul 19, 2018 | clinicaltrials |
| NCT02125240 | Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma(ICWIP) | unknown | Phase 3 | 124 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 16, 2018 | clinicaltrials |
| NCT02980536 | cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China | unknown | — | 129 | Berry Genomics Co., Ltd.INDUSTRY | 1 | Jul 11, 2018 | clinicaltrials |
| NCT02678806 | Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion(RHCC:BCLC-A) | unknown | N/A | 620 | Guangxi Medical UniversityOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT03383159 | Gut Microbiota Prediction of Metachronous Colorectal Neoplasms | unknown | — | 100 | First Affiliated Hospital of Harbin Medical UniversityOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT03570502 | Incidence of POPF in the Resection of the Left Pancreas With RFAT(RFATPancreas) | unknown | — | 38 | Hospital del MarOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT03129685 | Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma(NRU) | unknown | N/A | 12 | The National Ribat UniversityOTHER | 1 | Jun 12, 2018 | clinicaltrials |
| NCT03551444 | Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial(CAUTIOUS) | unknown | Phase 3 | 80 | Ain Shams UniversityOTHER | 1 | Jun 11, 2018 | clinicaltrials |
| NCT01681446 | Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression | unknown | Phase 3 | 296 | Fudan UniversityOTHER | 1 | Jun 1, 2018 | clinicaltrials |
| NCT03543397 | MRI in Ductal Carcinoma in Situ (DCIS) | unknown | — | 74 | University Hospital, Strasbourg, FranceOTHER | 1 | Jun 1, 2018 | clinicaltrials |
| NCT03341845 | Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC | unknown | Phase 2 | 40 | The Netherlands Cancer InstituteOTHER | 1 | May 21, 2018 | clinicaltrials |
| NCT01834963 | P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma. | unknown | Phase 2 | 66 | Kansai Hepatobiliary Oncology GroupNETWORK | 1 | May 18, 2018 | clinicaltrials |
| NCT03520257 | The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus | unknown | Phase 2 | 50 | Guangxi Medical UniversityOTHER | 0 | May 9, 2018 | clinicaltrials |
| NCT03518502 | Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis | unknown | Phase 4 | 130 | Korea UniversityOTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT03516448 | Expanding Phase III Study of Tyroserleutide for Injection | unknown | Phase 3 | 352 | Shenzhen Kangzhe Pharmaceutical Co., Ltd.INDUSTRY | 0 | May 4, 2018 | clinicaltrials |
| NCT03515369 | Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma | unknown | Phase 4 | 459 | Eastern Hepatobiliary Surgery HospitalOTHER | 0 | May 3, 2018 | clinicaltrials |
| NCT03285867 | Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma | unknown | — | 200 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Apr 30, 2018 | clinicaltrials |
| NCT03511703 | The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients | unknown | Phase 2 | 40 | Guangxi Medical UniversityOTHER | 0 | Apr 30, 2018 | clinicaltrials |
| NCT01135056 | Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)(SIRveNIB) | unknown | Phase 3 | 360 | Singapore General HospitalOTHER | 12 | Apr 24, 2018 | clinicaltrials |
| NCT03132740 | Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma | unknown | — | 2,000 | Zhujiang HospitalOTHER | 1 | Apr 19, 2018 | clinicaltrials |
| NCT03191123 | Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor | unknown | N/A | 100 | Huazhong University of Science and TechnologyOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT03257891 | Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines(CabACC) | unknown | Phase 2 | 25 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT03493763 | Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test | unknown | — | 300 | Shanghai Zhongshan HospitalOTHER | 1 | Apr 10, 2018 | clinicaltrials |
| NCT03486496 | Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation(Geber) | unknown | Phase 2 | 50 | Fujian Cancer HospitalOTHER_GOV | 1 | Apr 3, 2018 | clinicaltrials |
| NCT03468231 | HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC | unknown | Phase 3 | 300 | Sun Yat-sen UniversityOTHER | 1 | Mar 16, 2018 | clinicaltrials |
| NCT03464032 | A Study of BCD-135 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 30 | BiocadINDUSTRY | 1 | Mar 13, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT02942329 | Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer | unknown | Phase 1 / Phase 2 | 60 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Feb 26, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Sep 18, 2018source: clinicaltrials